Spanish science and technology parks met in Las Palmas Blog Post

Representatives of 64 Spanish science and technology parks met on 24 and 25 October in Gran Canaria as part of the second annual assembly of the Spanish Association of Science and Technology Parks (APTE). One of the most significant agreements adopted at this meeting, which was attended by Maria Terrades, CEO of the Barcelona Science Park, was the creation of a working group to implement the United Nations Sustainable Development Goals (SDGs) at all member parks.

 

DD BioLab strengthens its leadership in the Spanish biotechnology sector Blog Post

The acquisition of Cultek and Teknovas by the Dutscher Group, the leading independent distributor of laboratory supplies in Europe, its Spanish subsidiary, DD BioLab, as the leading supplier in Spain of scientific instruments, consumables and laboratory equipment for research in biotechnology and health. Since it was established in Barcelona Science Park in 2014, DD BioLab has registered sustained 39% annual growth. In 2018, its turnover was around €5M and it expects to exceed €10M in 2022. 

 

CataloniaBioHT participates in the Annual Advisory Committee of the Catalonia’s Cluster Programme Blog Post

Last Thursday, the president of CataloniaBio & HealthTech (CataloniaBioHT), Jaume Amat, participated in the Annual Advisory Committee of the Catalonia’s Cluster Programme, promoted by ACCIÓ, alongside the other presidents of the 30 accredited clusters. The association, founded in 2017 as a result of the merger of CataloniaBio and HeathTech Cluster and headquartered in the Barcelona Science Park, has over 160 companies and agents in the field of biomedicine and health. 

 

The MessyCheffy project won the challenge launched by the PCB, the IBEC and the IRB in the iFest Countdown Blog Post

MessyCheffy, an interactive physiotherapy game for children with muscular dystrophy, developed by the Yallow team from the University of Barcelona, has won the “Rare Diseases” challenge set by the Barcelona Science Park, the Institute for Bioengineering of Catalonia (IBEC) and the Institute for Research in Biomedicine (IRB Barcelona) as part of the iFest Countdown initiative. The young finalists of this programme presented their prototypes to a panel at the Auditorium Imagina Mediapro today at the iFest Demo Day, during an event chaired by the director of Catalunya Emprèn, Pere Condom. 

 

Meteosim implements the world’s first comprehensive air quality management system in Riyadh Blog Post

Meteosim, headquartered in the Barcelona Science Park (PCB), has implemented a first-of-its-kind system in Riyadh to integrate, in a single platform, the city’s air quality forecast, atmospheric chemical emergency management and any related decision making. This is the world’s most ambitious project in this field allowing to predict the air quality in any given street in the capital city of Saudi Arabia, which has over 8 million inhabitants.

 

Binucleated cells could be the key in heart regeneration Blog Post

A team of researchers, led by Xavier Trepat, from the Institute of Bioengineering of Catalonia (IBEC) in collaboration with the Centre for Regenerative Medicine in Barcelona (CMR [B]), have discovered a surprising mechanism that generates binucleated cells during the regeneration of the heart of the zebrafish, and could be associated with the extraordinary regenerative power of this animal. The results of the work has attracted the attention of researchers from all over the world, who see the range of possibilities that would be opened up if this mechanism of cell regeneration could be applied in human therapies.

 

CataloniaBio & HealthTech and Boston MassMEDIC join forces Blog Post

CataloniaBio & HealthTech –the association of companies in the biomedicine and health arena in Catalonia, based in the Barcelona Science Park– and the Massachusetts Medical Device Industry Council (MassMEDIC), the largest association of medical technology companies in the United States, have signed an agreement to foster innovation and collaborations in business and research among their members. 

 

GlyCardial Diagnostics wins the EmprendedorXXI 2019 Award in the ‘Health Tech’ category Blog Post

GlyCardial Diagnostics has won the  the EmprendedorXXI Award in the ‘Health Tech’ category, one of the six awards granted in its twelfth year to recognize those companies in Spain and Portugal with greatest growth potential in several sectors linked to the new innovation trends. The winners have been selected from 961 companies in Spain and Portugal. The biotechnology company, headquartered in the Barcelona Science Park, adds this award to the EmprendedorXXI Award in Catalonia, which it received on 9 May.

 

GlyCardial Diagnostics receives the EmprendedorXXI Award in Catalonia Blog Post

The companies GlyCardial Diagnostics, based in the Barcelona Science Park, and Mitiga Solutions, have been honoured with the EmprendedorXXI Award in Catalonia, which is promoted by CaixaBank –through DayOne, its specialized division that provides banking services for technology and innovation companies and its investors- and awarded jointly by the Ministry of Industry, Commerce and Tourism, through Empresa Nacional de Innovación, S.A. (ENISA). The award ceremony was held yesterday in the Recinte Modernista of the Hospital de Sant Pau as part of the ‘DayOne Innovation Summit’ event. Outside of the regional prize, next May 14th the sectorial EntrepreneurXXI Awards will be awarded to 6 nationwide companies with the highest growth potential in their sector.